Status:
COMPLETED
Epicardial Stimulation of the Cardiac Autonomic Nervous System
Lead Sponsor:
Rennes University Hospital
Conditions:
Cardiac Insufficiency
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of the EpiCANS study is to evaluate the technique of stimulation of the cardiac autonomic nervous system (SNAC) directly at the epicardial level in humans during heart surgery. Proof of...
Detailed Description
Isolated stimulation of the parasympathetic system induces a protective effect on long-term cardiac remodeling, but at the cost of inhibiting the sympathetic system. The role of the sympathetic system...
Eligibility Criteria
Inclusion
- Scheduled for elective cardiac surgery for valvular or coronary surgery
- Having received written and oral information about the protocol and having signed a written informed consent
- Affiliated or beneficiary of a social security plan
Exclusion
- Patient with an indication for cardiac surgery:
- Urgent or semi-urgent
- Aortic surgery
- Heart transplantation
- Mechanical circulatory assistance
- Patients who have already undergone cardiac surgery
- Adults under legal protection (safeguard of justice, curatorship, guardianship), persons deprived of liberty, pregnant or breastfeeding women, minors, persons unable to express their consent, persons hospitalized for a different reason
Key Trial Info
Start Date :
August 16 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 13 2023
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT05255952
Start Date
August 16 2022
End Date
November 13 2023
Last Update
September 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Rennes
Rennes, France, 35033